Table 2

Changes in C-peptide levels of the T1D subjects after treatment at 12 weeks.

Patient No.

C-peptide (ng/ml)

Changes in C-peptide levels (ng/ml)


Group A:


1

0.56

↑ 0.26


2

0.98

↑ 0.42


3

0.54

↑ 0.42


4

1.1

↑ 0.46


5

0.52

↑ 0.34


6

0.78

↑ 0.60


Mean

0.75

↑ 0.42


(SD)

(0.24)

(0.12)


Group B


7

0.25

↑ 0.24


8

0.11

↑ 0.10


9

0.28

↑ 0.27


10

0.43

↑ 0.42


11

0.11

↑ 0.10


12

0.12

↑ 0.11


Mean

0.22

↑ 0.21


(SD)

(0.13)

(0.13)


Control Group


13

0.41

↑ 0.04


14

0.38

↓ 0.17


15

0.35

↑ 0.05


Mean

0.38

↓ 0.03


(SD)

(0.03)

(0.12)


Levels of plasma C-peptide before treatment served as baseline for comparison. The level of C-peptide was increased (↑); the level of C-peptide was decreased (↓).

Zhao et al. BMC Medicine 2012 10:3   doi:10.1186/1741-7015-10-3

Open Data